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Abstract
Aim: The aim of this study was to see whether the advent of modern
implant systems, and the refinement of free flap techniques, negate the
effect of radiotherapy in patients with oral cancer who undergo dental
implant–based oral rehabilitation.
Materials and method: A retrospective study was performed to look at the
success rates of implants placed in all patients, in a 3 year period at the
Queen Elizabeth Hospital, Birmingham. Survival rates in irradiated
patients were compared with success rates in patients who did receive
radiotherapy.
Results and conclusions: The rate of failure is comparable in the no
radiotherapy group (1.12%) and post-radiotherapy group (1.76%). Our
study shows that there was no significant difference in survival
when implants were placed in native, grafted bone or in free flap recon-
structions in irradiated head and neck cancer patients. Ultimately, the
current evidence is not strong enough to prove whether the advent of
modern implants systems, and the refinement of free flap techniques,
does negate the effect of radiotherapy in patients with oral cancer under-
going dental implant–based oral rehabilitation. There is a need to perform
a prospective clinical trial to observe clinical outcomes in both patients
who have received radiotherapy and those who have not received
radiotherapy.
Clinical relevance
It is an integral part of the rehabilitation of patients
with oral cancer to attempt to return them to their
previous functional state. Radiotherapy is seen to be a
major factor in the exclusion of patients receiving
dental implant–based rehabilitation. The refinement of
both newer implant systems, combined with free flap
surgical technique, has led to improved implant-based
oral rehabilitation as well as a reduced failure rate. This
article, while being a retrospective study, may show
evidence that the gap in implant failure rate is closing
between patients who have been irradiated and those
who have not.
Introduction
Historically, the placement of implants into native bone
in an irradiated field, or into a bony free flap within an
irradiated field had a significantly higher failure rate
than implants placed into virgin native bone. Even in
small studies1 the success rates for implants placed into
an irradiated mandible were 77.5% and as low as 63%2
in the maxilla. Currently, the expected success rates of
implant supported, cantilevered, fixed dental prosthe-
ses in non-irradiated native bone (combined mandible
and maxilla) are 94.3% at 5 years3.
It is an integral part of the rehabilitation of patients
with oral cancer to attempt to return them to their
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previous functional state. For patients treated for oral
cancer, major concerns may include their ability to
chew, speak and swallow. If these issues are not
addressed, this can lead to psychological difficulties4.
The loss of teeth is a determinant of a patient’s health-
related quality of life, with a reduced self-perceived oral
health status associated with greater numbers of
missing teeth. This was confirmed by the Second
National Survey of Health-Related Quality of Life
Questionnaires in Head and Neck Oncology5. There is,
therefore, a patient need and demand for dental reha-
bilitation that aims to restore oro-facial form and func-
tion and general well-being.
Materials andmethod
A retrospective study was performed to look at the
success rate of implants placed at Queen Elizabeth
Hospital, Birmingham, between March 2009 and
March 2012. A variety of modalities were used to
acquire the data for this study. Theatre and laboratory
log books were used to identify those patients who had
dental implants placed in this period. The clinical notes
were then reviewed for each patient, and the patients
were categorised into:
1 Oncology patients with free flap reconstruction of
the maxilla or mandible who had received post-
operative radiotherapy.
2 Oncology patients with free flap reconstruction who
had not received post-operative radiotherapy and non-
oncology patients (trauma, deformity, hypodontia,
cleft,other).
For each case, the site of the implant or implants was
recorded, whether hard and/or soft tissue augmenta-
tion was required and the outcome of each implant. If
there was an adverse outcome or complication, then
the reason for this was recorded. Only those patients
who had had Straumann implants placed were
included in this study, to reduce variability. Average
follow-up was 2.7 years. All patients in the post-
radiotherapy group had received their implants after
they had received radiotherapy. All implants were
placed by either a consultant, or a Specialist Registrar
under the supervision of a consultant. All patients had
intravenous antibiotics given on induction and were
given a 5 day post-operative course of oral antibiotics.
The survival of the implants was assessed by analysis of
notes, clinic letters and radiographs.
These results were then analysed.
Results
Table 1 shows that proportionately more implants were
placed in the maxilla of the no radiotherapy group, and
proportionately more implants were placed in the
mandible of the post-radiotherapy group. A chi-
squared test was performed on these data, and it was
found to be statistically significant (chi-square = 13.82,
1 degree of freedom, two-tailed P-value = 0.0002).
Table 2 demonstrates that the post-radiotherapy
group had a higher proportion of active smokers than
the no radiotherapy group. A chi-squared test was
performed on these data, and it was not found to be
statistically significant (two-tailed P-value = 0.879).
Table 3 shows that the no radiotherapy group had
significantly more patients in the American Society of
Anaesthesiologists (ASA) group 1 than the post-
radiotherapy group. There was a much greater propor-
tion of patients with ASA = 2 and 3 in the post-
radiotherapy group. This suggests that this group has
greater comorbidities than the no radiotherapy group.
Table 4 shows that 18% of the implants placed in
post-radiotherapy group were placed in bony free flaps,
and 82% were placed in native bone.
Table 5 shows that a greater proportion of implants
were loaded in the no radiotherapy group (88%)
Table 1 Numberof implantsplaced, in each jawandwhether thepatients
hadundergone radiotherapyornot
Numberof implants
Post-radiotherapy No radiotherapy
Maxilla 152 159
Mandible 189 107
Total 341 266
Table 2 Relevant smoking information regardingpatients
Post-radiotherapy
group (%)
No radiotherapy
group (%)
Percentageofpatients smoking
at timeof implantplacement
46 15
Percentageofpatientswhowere
previous smokers
73 27
Table 3 AmericanSocietyofAnaesthesiologist (ASA)Physical Status
Classificationof thepatients inwhomthe implantswereplaced
ASA
classification
Post-radiotherapy
group (%)
No radiotherapy
group (%)
1 5 73
2 40 17
3 53 10
4 2 0
5 0 0
6 0 0
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compared with the post-radiotherapy group (70%).
This may well be due to recurrence of disease, new
comorbidities and willingness to undergo further
treatment.
Table 6 shows that an implant failure rate of 1.76%
in the post-radiotherapy group compared with the no
radiotherapy group (1.12%). The loss of one free flap
was a significant complication and resulted in the need
for a second bony free flap, a 16 day hospital stay and
the additional free flap donor site morbidity to the
patient. There was an increased rate of peri-implantitis
in the post-radiotherapy group (2.90%) compared
with the no radiotherapy group (1.50%). Nerve inju-
ries only occurred in the no radiotherapy group (n = 2);
however, these were both temporary and resolved
within 3 months. There was no statistical difference in
the complication rates between the two groups.
Discussion
The causes contributing to implant failure are recog-
nised as (a) implant location and (b) radiotherapy.
Neither smoking nor systemic health factors were
found to adversely affect implant integration from
abutment connection through 2 years active function6.
Seventy-three per cent of the no radiotherapy group
(Table 3) were ASA grade 1 compared with 5% of the
post-radiotherapy group. This suggests that the no
radiotherapy group had significantly less comorbidities
than the post-radiotherapy group, which had the
highest proportion of patients in the ASA 3 Group
(53%). This difference in the level of comorbidities may
contribute to the failure rate of the implants. It is likely
that loco-regional disease recurrence and a higher rate
of ASA 3 patients is the reason behind the 30%
(Table 5) post-radiotherapy patients not having their
implants restored.
In our study (Table 2), this demonstrated that there
was no statistically significant difference in the number
of smokers and past smokers between the two groups
(P = 0.879). Given that the rate of failure is comparable
in the no radiotherapy group (1.12%) and post-
radiotherapy group (1.76%), this suggests that
smoking is not a significant cause of failure.
There is controversyoverwhetherplacing implants in
bone within a period shorter than 12 months after
radiotherapy may result in a higher risk of failure. In a
meta-analysis, the pooled relative risk (RR) of failure
was RRpooled = 1.34. However, if one study was removed,
itgaveanoverallRRof failureofRRpooled = 1.08
7.
This article suggests that radiotherapy may not play
as significant a role in the failure of implants as was
thought. Our study (Table 6) shows a 1.76% failure
rate that is similar to the failure rate (1.4%) in a pro-
spective 5 year clinical trial8 of implants placed in non-
irradiated patients.
The same trial8 found that during a 5 year period
from 2004 to 2009 implants placed in irradiated bone
had a success rate of 89.4%. This shows that expecta-
tions of survival have improved markedly from 1997
when success rates in irradiated patients ranged from
77.5% to 85.5%. The improvement may be influenced
by which implant system was used9, or it may be due to
improved surgical technique, better restorative tech-
Table 4 Proportionof implantsplaced into freeflapand implantsplaced
intonativebone
Post-radiotherapy
group (%)
No radiotherapy
group (%)
Implantsplaced in freeflapbone 18 7
Implantsplaced innativebone 82 93
Table 5 Numberof implants loaded (asofAugust 2013)
Post-radiotherapy
group
No radiotherapy
group
Maxilla 106 142
Mandible 134 93
Total 240 235
Table 6 Numberof complications that arose
Post-radiotherapy No
radiotherapy
Fisher exact
test score
Significant –
yes/no
Implant failure 6 (1.76%) 3 (1.12%) 0.73 No
Nerve injury 0 (0.00%) 2 (0.75%) 0.19 No
Peri-implantitis 10 (2.90%) 4 (1.50%) 0.29 No
Freeflap failure 1 (0.29%) 0 (0.00%) N/A N/A
Soft tissueproblem (i.e. lossof
overlying skinpaddleor split
thickness skingraft or
gingival loss)
2 (0.58%) 1 (0.38%) 1.0 No
Total 19 (5.57%) 10 (3.75%) 0.34 No
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niques, improved oral hygiene10 and restorative con-
sultants who have rehabilitation of oral cancer patients
as part of their job plan. The advent of intensity-
modulated radiotherapy treatment (IMRT) may in the
future reduce the failure rate of dental implants in the
post-radiotherapy group. This is because IMRT allows
higher radiation doses to be focused to regions within
the tumour while minimising the dose to the sur-
rounding normal structures.
Our study shows that there was no significant dif-
ference in survival when implants were placed in
native, grafted bone or in free flap reconstructions in
irradiated head and neck cancer patients. Roumanas2
and Esser1 showed that outcomes for implants that are
placed in native bone, the survival was significantly
influenced by the location of the implant (maxilla or
mandible, anterior or posterior).
The loss of a free flap is a significant cause of mor-
bidity to the patient and must not be underestimated.
However free flap failure is a recognised risk if dental
implants are placed, as in the process of placing implant
the blood supply to the free flap may be compromised.
In a case series of 59 fibula-free flaps (into which
implants were placed), three failed and had to be
removed, nine underwent partial necrosis involving
the bone segment and/or the skin paddle but survived,
whereas the remaining 47 healed uneventfully11.
Nooh12 performed a review of 38 articles on implant
survival in irradiated patients, which were published
between 1990 and 2012. He found that overall implant
survival rates with radiation therapy done pre- and
post-implantation were 88.9% and 92.2%, respec-
tively. He found that in patients who had had pre-
implantation radiation therapy, the implant survival
rate was significantly higher for the mandible (93.3%)
than for the maxilla (78.9%). It was concluded that
the anatomical site of implant placement in pre-
implantation radiation therapy was the most pertinent
variable affecting implant survival, with a better sur-
vival rate in the mandible compared with the maxilla.
Although these success rates are lower than the one in
this study, it must be noted that studies that were pub-
lished 23 years ago were included in the article, and it is
well acknowledged that success rates have increased in
recent years3.
Ultimately, the current evidence is not strong enough
to prove whether the advent of modern implants
systems, and the refinement of free flap techniques does
negate the effect of radiotherapy in patients with oral
cancer undergoing dental implant–based oral rehabili-
tation. There is a need to perform a prospective clinical
trial to observe clinical outcomes in both patients who
have received radiotherapy and those who have not
received radiotherapy. This should look at comorbidities
in both groups, standard radiotherapy versus IMRT,
osteoradionecrosis rates, as well as quality of life
improvementsassociatedwithdental implants.
References
1. Esser E, Wagner W. Dental implants following radical
oral cancer surgery and adjuvant radiotherapy. Int J
Oral Maxillofac Implants 1997;12:552–7.
2. Roumanas ED, Chang TL, Beumer J. Use of
osseointegrated implants in the restoration of head and
neck defects. J Calif Dent Assoc 2006;34:711–18.
3. Aglietta M, Siciliano VI, Zwahlen M, Bragger U,
Pjetursson BE, Lang NP et al. A systematic review of the
survival and complication rates of implant supported
fixed dental prostheses with cantilever extensions after
an observation period of at least 5 years. Clin Oral
Implants Res 2009;20:441–51.
4. Pace-Balzan A, Sogers SN. Dental rehabilitation after
surgery for oral cancer. Curr Opin Otolaryngol Head
Neck Surg 2012;20:109–13.
5. Kanatas AN, Mehenna HM, Lowe D, Rogers SN. A
second national survey of health-related quality of life
questionnaires in head and neck oncology. Ann R Coll
Surg Engl 2009;91:420–5.
6. Carr AB. Implant location and radiotherapy are the
only factors linked to 2-year implant failure. J Evid
Based Dent Pract 2012;12(Suppl.):217–19.
7. Claudy MP, Miguens SA Jr, Celeste RK,
Camara Parente R, Hernandez PA, da Silva AN Jr. Time
Interval after Radiotherapy and Dental Implant Failure:
Systematic Review of Observational Studies and Meta-
Analysis. Clin Implant Dent Relat Res. doi: 10.1111/
cid.12096 [Epub ahead of print].
8. Korfage A, Schoen PJ, Raghoebar GM, Roodenburg JL,
Vissink A, Reintsema H. Benefits of dental implants
installed during ablative tumour surgery in oral cancer
patients: a prospective 5-year clinical trial. Clin Oral
Implants Res 2010;21:971–9.
9. Buddula A, Assad DA, Salinas TJ, Garces YI. Survival of
dental implants in native and grafted bone in irradiated
head and neck cancer patients: a retrospective analysis.
Indian J Dent Res 2011;22:644–8.
10. Joyce M. The care and maintenance of dental implants:
a team approach. Prim Dent J 2013;2:65–8.
11. Chiapasco M, Biglioli F, Autelitano L, Romeo E, Brusati
R. Clinical outcome of dental implants placed in fibula-
free flaps used for reconstruction of maxillo-
mandibular defects following ablation for tumors or
osteoradionecrosis. Clin Oral Implants Res 2006;17:
220–8.
12. Nooh N. Dental implant survival in irradiated oral
cancer patients: a systematic review of the literature. Int
J Oral Maxillofac Implants 2013;28:1233–42.
Oral Surgery 8 (2015) 152--155.
© The British Association of Oral Surgeons and John Wiley & Sons Ltd
155
Hammond et al. Post-radiotherapy implant success
2014
Conflict of interest
The authors confirm that they have no conflict of
interest.
